Literature DB >> 15292543

The cost of schizophrenia treatment in Taiwan.

Hui-Chu Lang1, Tung-Pine Su.   

Abstract

The costs associated with mental illness in Taiwan have been the subject of discussion and concern in Taiwan's Bureau of National Health Insurance. The authors report the first estimates of these costs on the basis of national data for 52,432 patients treated in 1999. Total schizophrenia-related health care expenditure was estimated at 112.4 million dollars, which constituted 1.2 percent of national health care expenditures that year. The cost per outpatient visit was 57 dollars, the cost per admission was 1,123 dollars, and the annual average direct cost of treating a person with schizophrenia was 2,144 dollars.

Entities:  

Mesh:

Year:  2004        PMID: 15292543     DOI: 10.1176/appi.ps.55.8.928

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  10 in total

1.  Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia.

Authors:  Pudtan Phanthunane; Theo Vos; Harvey Whiteford; Melanie Bertram
Journal:  Cost Eff Resour Alloc       Date:  2011-05-13

Review 2.  The Cost of Relapse in Schizophrenia.

Authors:  Mark Pennington; Paul McCrone
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

3.  Factors associated with dental caries among institutionalized residents with schizophrenia in Taiwan: a cross-sectional study.

Authors:  Kuan-Yu Chu; Nan-Ping Yang; Pesus Chou; Hsien-Jane Chiu; Lin-Yang Chi
Journal:  BMC Public Health       Date:  2010-08-13       Impact factor: 3.295

4.  Schizophrenia in Thailand: prevalence and burden of disease.

Authors:  Pudtan Phanthunane; Theo Vos; Harvey Whiteford; Melanie Bertram; Pichet Udomratn
Journal:  Popul Health Metr       Date:  2010-08-17

5.  Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People's Republic of China.

Authors:  Jing Wu; Xiaoning He; Li Liu; Wenyu Ye; William Montgomery; Haibo Xue; Jeffery S McCombs
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-07       Impact factor: 2.570

Review 6.  Necessity of oral health intervention in schizophrenic patients - A review.

Authors:  Swati Gupta; Pratibha Pk; Richa Gupta
Journal:  Nepal J Epidemiol       Date:  2016-12-31

7.  The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy.

Authors:  William Montgomery; Li Liu; Michael D Stensland; Hai Bo Xue; Tamas Treuer; Haya Ascher-Svanum
Journal:  Clinicoecon Outcomes Res       Date:  2013-08-14

8.  Healthcare in schizophrenia: effectiveness and progress of a redesigned care network.

Authors:  Dong-Sheng Tzeng; Li-Chiu Lian; Chin-Un Chang; Chun-Yuh Yang; Gian-Tin Lee; Peter Pan; For-Wey Lung
Journal:  BMC Health Serv Res       Date:  2007-08-17       Impact factor: 2.655

Review 9.  Global economic burden of schizophrenia: a systematic review.

Authors:  Huey Yi Chong; Siew Li Teoh; David Bin-Chia Wu; Surachai Kotirum; Chiun-Fang Chiou; Nathorn Chaiyakunapruk
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-16       Impact factor: 2.570

Review 10.  Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples.

Authors:  Lan Gao; Hao Hu; Fei-Li Zhao; Shu-Chuen Li
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.